MZHNanofilm Technologies International Limited

🇸🇬 Singapur Borsası
0.81
SGD
Analysis Scores
Lothien Robustness Score?
62/100
Strong
Neden bu skor?
Damodaran ?
42/100
Dalio Risk ?
84/100
Piotroski ?
5/9
Neutral
Graham ?
S$0.5
Pahalı
Active Metric?
4/4
Confidence?
72%
Lothien Robustness Summary
78/100
Lothien Sağlamlık: Çok Güçlü (78/100)
Temel göstergelerin büyük çoğunluğu pozitif. Kârlılık, büyüme ve değerleme açısından güçlü görünüm. | Kısa Vade: Olumlu | Uzun Vade: Nötr | Pozitif: 8 | Negatif: 2 | Nötr: 0
Net Kâr Pozitif
Son çeyrekte S$14M net kâr açıklandı. Şirket kârlı.
Çeyreklik Kâr Artışı
Net kâr bir önceki çeyreğe göre %+390.6 arttı (S$3M → S$14M). Kısa vadede olumlu momentum.
Yıllık Kâr Büyümesi Güçlü
Geçen yılın aynı dönemine göre net kâr %+390.6 arttı. Büyüme trendi sağlıklı.
Hasılat Büyümesi Güçlü
Satış gelirleri çeyreklik %+310.7 arttı (S$61M → S$251M). Talep güçlü.
Yıllık Hasılat Büyümesi Güçlü
Yıllık hasılat %+310.7 arttı. Şirket büyüyor.
Güçlü Likidite
Cari oran 3.42x — kısa vadeli borçları rahat karşılıyor.
FAVÖK Büyümesi
FAVÖK çeyreklik %+280.9 arttı (S$15M → S$57M). Operasyonel verimlilik artıyor.
Düşük EV/EBITDA
EV/EBITDA: 5.3. Operasyonel kârlılığa göre ucuz değerleme.
Düşük ROE
ROE: %4.6. Sermaye getirisi yetersiz — enflasyonun altında.
Sonraki Çeyrek: Düşüş Beklentisi
Tahminine göre kâr %-60.4 düşebilir. Sonraki bilançoya dikkat.

Data date 2026-10-23 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date 2026-10-23
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Risk Analysis (VaR) Çok Yüksek
252 days
Annual Volatility ?
%67.7
VaR 95% ?
%6.87
daily max loss
VaR 99% ?
%9.77
daily max loss
CVaR 95% ?
%7.71
expected loss (tail)
Max Drawdown ?
%53.0
13.05.2026 → 15.10.2026
Skewness ?
3.40
Parametrik%6.87
Historik%4.74
Cornish-Fisher%-0.82
Return Distribution
Valuation
Potential?
+7.4%
ROIC ?
3.2%
DCF Value ?
1.28
Debt Cycle?
Early Expansion
Balance Sheet Analysis? Q2026/6
Yıllık net kâr büyümesi %+390.6
Yıllık hasılat büyümesi güçlü (%+310.7)
Brüt kâr marjı güçlü: %38.8
Net kâr marjı: %5.8
FAVÖK marjı: %22.7
Toplam borç: 103.5M SGD
Net borç: 14.8M SGD
Borç/Özkaynak oranı düşük: 0.23x
Cari oran güçlü: 3.42x — yükümlülükler rahat karşılanıyor
Nakit ve benzerleri: 88.7M SGD
İşletme nakit akışı pozitif: 73.4M SGD
Serbest nakit akışı pozitif: 9.7M SGD
ROE düşük: %3.2
ROA: %2.3
Ödenmiş sermaye: 651.5M SGD
Net işletme sermayesi pozitif: 167.1M SGD
Son 7 çeyrek ardışık kâr
Fiyat TRAMA-99 altında: %-21.0 — teknik trend olumsuz
Direnç seviyesi: TRAMA-99 = 1.03 SGD
Fundamental & Technical Analysis
Profitability
Net Profit Margin %5.8
Net profit margin %5.8 — positive but low. Compared to previous quarter +0.9 point increase.
ROE - Return on Equity (TTM) %4.6
ROE %4.6 — low return on equity.
EBITDA Margin %22.7
EBITDA margin %22.7 — good operational performance.
Gross Profit Margin %38.8
Gross profit per revenue %38.8. Evaluate relative to sector.
Free Cash Flow Margin (TTM) %-0.3
TTM Free Cash Flow is %-0.3'i. Negative FCF — company consuming cash.
Valuation
P/E Ratio 19.4x Sector: 12.4x
F/K 19.4x — sector median's (12.4x) %57 above. Expensive zone.
P/B Ratio 1.18x Sector: 1.49x
PD/DD 1.18x — sector median (1.49x) below or near. Reasonable valuation.
EV/EBITDA 5.3x Sector: 6.0x
EV/EBITDA 5.3x — sector median (6.0x) in line.
Indebtedness
Current Ratio 3.42x
Current ratio 3.42x — current assets are 2x short-term liabilities. Very healthy liquidity.
Net Debt / EBITDA 1.0x
Net Debt/EBITDA 1.0x — very low debt burden. Company can repay debt quickly.
Debt / Equity 0.23x
Low leverage — majority of assets financed by equity.
Interest Coverage 46.7x
Interest coverage 46.7x — very wide margin for paying interest expenses.
Growth
Revenue Growth (YoY) %+310.7
Revenue YoY %310.7 grew (2026/6) — strong growth. Sector expansion and/or market share increase.
Net Profit Growth (YoY) %+390.6
Net profit YoY %390.6 increased (2026/6) — extraordinary profit growth.
Seasonality Analysis Q2 (Nis-Haz)
Historically strongest quarter: Q2 (Apr-Jun) (avg. profit 6.5M). Weakest quarter: Q4 (Oct-Dec) (avg. profit 2.4M).
Score Explanations
Lothien Robustness
62/100
Good robustness (62/100). The company shows a generally balanced financial profile; some areas have room for improvement.
Strong
Potential
+7.4%
Plus %7.4 expected value (0.87) vs current price comparison. 4/4 valuation models could be calculated. Model confidence %72.
Components: PE target: 0.50 | P/B target: 1.03 | EV/EBITDA target: 0.91 | DCF target: 1.28
Damodaran Valuation
42/100
Low Damodaran score (42/100). ROIC (%3.2) below cost of capital. DCF analysis does not support current price.
Weak
Dalio Risk Analysis
84/100
Low debt risk (84/100). Interest coverage ratio 46.7x — strong. Debt/EBITDA 1.0x — in healthy range.
Leverage: 91/100 | Debt Service: 100/100 | Quality: 59/100
ROIC - Return on Capital
%3.2
ROIC (%3.2) cost of capital (11.6%) below → destroying value.
WACC: %11.6
DCF Discounted Cash Flow
1.28
DCF modeli 1.28 target value produced — compared to current price %58.1 undervalued.
Current price: 0.81
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
5/9
Moderate Piotroski (5/9). Some balance sheet criteria met, some missing.
Neutral
Graham Intrinsic Value
S$0.5
Expensive
⚖️ Sector Comparison
P/E Ratio
19.4x vs 12.4x
Sector median's %57 above — expensive
P/B Ratio
1.18x vs 1.49x
Compared to sector %21 cheaper (by book value)
EV/EBITDA
5.3x vs 6.0x
Compared to sector %11 lower EV/EBITDA
ROIC vs WACC
%3.2 vs %11.6 WACC
ROIC 8.4 bps below cost of capital
Net Profit Margin (TTM)
%5.4 vs %23.5 EBITDA margin
TTM net profit margin %5.4
TRAMA-99 Trend — Strong Downtrend
Price (0.81), TRAMA-99 line's %21.0 below. Significant downtrend. TRAMA line acts as strong technical resistance.
Price:: 0.81
TRAMA: 1.03
Difference: %-21.0
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
RSI (14) ?
Bollinger Bands ?
MACD ?
Gold-Based Price + TRAMA (Stock / Gram Gold) ?
P/E Ratio ?
P/B Ratio ?
EBITDA ?
Net Working Capital ?
Current Ratio ?
MZH — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.